Why the study?
Are beta blockers or amiodarone superior to calcium channel blockers as first-line therapy for new onset atrial fibrillation in critically ill ICU patients?
Are beta blockers or amiodarone superior to calcium channel blockers as first-line therapy for new onset atrial fibrillation in critically ill ICU patients?
In critically ill patients with new-onset atrial fibrillation, limited evidence suggests beta-blockers or amiodarone may be preferred over CCBs, and routine therapeutic anticoagulation is not currently supported.
Answers are grounded in this paper and cite their sources.
May guide initial therapy choice away from CCBs in ICU new-onset AF; leaves open anticoagulation role pending definitive trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Drikite et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: